Marker Therapeutics Inc (MRKR)

[Phantom Lord]

I got a response to my email this morning regarding the pancreatic trial.

It basically said right now they are actively watching arm A which is fully enrolled at 13 patients. They are looking into avenues to further advance this group beyond just monitoring the patients for progression free survival and overall survival. Once the company has this figured out we should be getting an update. No timeframe though so it could come by the end of this year or sometime into next year. If I had to guess I would assume sometime Q1 would be reasonable.

Company is fairly busy through he end of the year but I am trying too get a call set up for early January. If anyone has things they would like to have addressed let me know and I will see about getting some answers. Keep the requests respectful and logical. Trial info, financing info, etc. I do plan on addressing the company's communication, or lack thereof, as I know that has been a sticking point for many here.